Benign course in multiple sclerosis: a review

G S M Ramsaransing1, J De Keyser

  • 1Department of Neurology, University Medical Centre Groningen, Groningen, The Netherlands.

Insights

Identifying patients with benign multiple sclerosis (MS) is challenging. Maintaining neural conduction within lesions is key to a benign MS disease course.

Area of Science:

  • Neurology
  • Neuroimmunology

Background:

  • A subset of multiple sclerosis (MS) patients exhibits minimal disease progression, termed 'benign' MS.
  • Predicting a benign MS course at onset and identifying influencing factors remain difficult despite extensive research.
  • Understanding the factors contributing to benign MS is crucial for patient management.

Purpose of the Study:

  • To explore the characteristics and potential predictors of benign multiple sclerosis.
  • To investigate the underlying mechanisms that allow some MS patients to maintain a non-progressive disease course.

Main Methods:

  • Review of historical and current research on benign MS.
  • Analysis of factors potentially influencing disease progression in multiple sclerosis.
  • Focus on the role of neural conduction within central nervous system lesions.

Main Results:

  • Benign MS is recognized but difficult to predict at disease onset.
  • Multifactorial influences on MS severity are acknowledged but not fully elucidated.
  • Preservation of neural conduction within lesions appears critical for a benign outcome.

Conclusions:

  • The key to a benign multiple sclerosis (MS) course lies in maintaining or restoring neural conduction within central nervous system lesions.
  • Further research is needed to identify reliable predictors for benign MS and understand its long-term course.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.